Literature DB >> 28421313

Association between forkhead-box P2 gene polymorphism and clinical symptoms in chronic schizophrenia in a Chinese population.

Wenwang Rao1, Xiangdong Du2, Yingyang Zhang2, Qiong Yu3, Li Hui2, Yaqin Yu1, Changgui Kou1, Guangzhong Yin2, Xiaomin Zhu2, Lijuan Man2, Jair C Soares4, Xiang Yang Zhang5,6.   

Abstract

The forkhead-box P2 (FOXP2) gene polymorphism has been reported to be involved in the susceptibility to schizophrenia; however, few studies have investigated the association between FOXP2 gene polymorphism and clinical symptoms in schizophrenia. This study investigated whether the FOXP2 gene was associated with the development and symptoms of schizophrenia in relatively genetically homogeneous Chinese population. The FOXP2 rs10447760 polymorphism was genotyped in 1069 schizophrenia inpatients and 410 healthy controls using a case-control design. The patients' psychopathology was assessed by the Positive and Negative Syndrome Scale (PANSS). We found no significant differences in the genotype and allele distributions between the patient and control groups. Interestingly, we found significant differences in PANSS total, positive symptom, and general psychopathology scores between genotypic subgroups in patients, with the higher score in patients with CC genotype than those with CT genotype (all p < 0.05). After adjusting demographic and clinical variables, the difference still remained significant for the PANSS positive symptom score and general psychopathology (both p < 0.05). Our findings suggest that the FOXP2 rs10447760 polymorphism may not contribute to the development of schizophrenia, but may contribute to the clinical symptoms of schizophrenia among Han Chinese.

Entities:  

Keywords:  Association; Clinical symptoms; FOXP2; Genotype; Polymorphism; Schizophrenia

Mesh:

Substances:

Year:  2017        PMID: 28421313     DOI: 10.1007/s00702-017-1723-x

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  31 in total

1.  FoxP2 is significantly associated with schizophrenia and major depression in the Chinese Han population.

Authors:  Tao Li; Zhen Zeng; Qian Zhao; Ti Wang; Ke Huang; Junyan Li; You Li; Jie Liu; Zhiyun Wei; Yang Wang; Guoyin Feng; Lin He; Yongyong Shi
Journal:  World J Biol Psychiatry       Date:  2012-03-09       Impact factor: 4.132

Review 2.  Practice guideline for the treatment of patients with schizophrenia, second edition.

Authors:  Anthony F Lehman; Jeffrey A Lieberman; Lisa B Dixon; Thomas H McGlashan; Alexander L Miller; Diana O Perkins; Julie Kreyenbuhl
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

Review 3.  Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework.

Authors:  A H Fanous; K S Kendler
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

4.  Localisation of a gene implicated in a severe speech and language disorder.

Authors:  S E Fisher; F Vargha-Khadem; K E Watkins; A P Monaco; M E Pembrey
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

5.  Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy.

Authors:  J M Kane; E Aguglia; A C Altamura; J L Ayuso Gutierrez; N Brunello; W W Fleischhacker; W Gaebel; J Gerlach; J D Guelfi; W Kissling; Y D Lapierre; E Lindström; J Mendlewicz; G Racagni; L S Carulla; N R Schooler
Journal:  Eur Neuropsychopharmacol       Date:  1998-02       Impact factor: 4.600

6.  A forkhead-domain gene is mutated in a severe speech and language disorder.

Authors:  C S Lai; S E Fisher; J A Hurst; F Vargha-Khadem; A P Monaco
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

7.  John Nash, game theory, and the schizophrenic brain.

Authors:  Donald Capps
Journal:  J Relig Health       Date:  2011-03

8.  Nuclear schizophrenic symptoms as a window on the relationship between thought and speech.

Authors:  T J Crow
Journal:  Br J Psychiatry       Date:  1998-10       Impact factor: 9.319

Review 9.  Chlorpromazine equivalent doses for the newer atypical antipsychotics.

Authors:  Scott W Woods
Journal:  J Clin Psychiatry       Date:  2003-06       Impact factor: 4.384

Review 10.  The cortical microstructural basis of lateralized cognition: a review.

Authors:  Steven A Chance
Journal:  Front Psychol       Date:  2014-07-30
View more
  8 in total

Review 1.  The Brain Connectome for Chinese Reading.

Authors:  Wanwan Guo; Shujie Geng; Miao Cao; Jianfeng Feng
Journal:  Neurosci Bull       Date:  2022-05-16       Impact factor: 5.271

2.  FOXP2 contributes to the cognitive impairment in chronic patients with schizophrenia.

Authors:  Xiaoe Lang; Wenzhong Zhang; Xinxin Song; Guangya Zhang; Xiangdong Du; Yongjie Zhou; Zezhi Li; Xiang Yang Zhang
Journal:  Aging (Albany NY)       Date:  2019-08-19       Impact factor: 5.682

3.  Association between clinical symptoms and apolipoprotein A1 or apolipoprotein B levels is regulated by apolipoprotein E variant rs429358 in patients with chronic schizophrenia.

Authors:  Wenwang Rao; Xiangfei Meng; Keqing Li; Yunshu Zhang; Xiang Yang Zhang
Journal:  Ann Gen Psychiatry       Date:  2021-12-20       Impact factor: 3.455

4.  Sexual dimorphism in the relationship between Forkhead-Box P2 and BMI with cognitive deficits in schizophrenia.

Authors:  Mi Yang; Ying Cui; Mei Xue; Mattew T Forster; Xiaoe Lang; Meihong Xiu; Zezhi Li; Xiangyang Zhang
Journal:  Front Aging Neurosci       Date:  2022-08-03       Impact factor: 5.702

5.  FOXP2 expression and gray matter density in the male brains of patients with schizophrenia.

Authors:  Julio Sanjuán; Xochitl Helga Castro-Martínez; Gracián García-Martí; Javier González-Fernández; Roberto Sanz-Requena; Josep María Haro; J Javier Meana; Luis Martí-Bonmatí; Juan Nacher; Noelia Sebastiá-Ortega; Javier Gilabert-Juan; María Dolores Moltó
Journal:  Brain Imaging Behav       Date:  2021-06       Impact factor: 3.978

6.  Interstitial deletion within 7q31.1q31.3 in a woman with mild intellectual disability and schizophrenia.

Authors:  Keiko Akahoshi; Toshiyuki Yamamoto
Journal:  Neuropsychiatr Dis Treat       Date:  2018-07-05       Impact factor: 2.570

7.  Neuregulin 3 rs10748842 polymorphism contributes to the effect of body mass index on cognitive impairment in patients with schizophrenia.

Authors:  Yongjie Zhou; Yuhuan Li; Yujie Meng; Jiesi Wang; Fengchun Wu; Yuping Ning; Yi Li; Ryan M Cassidy; Zezhi Li; Xiang Yang Zhang
Journal:  Transl Psychiatry       Date:  2020-02-11       Impact factor: 6.222

Review 8.  Molecular networks of the FOXP2 transcription factor in the brain.

Authors:  Joery den Hoed; Karthikeyan Devaraju; Simon E Fisher
Journal:  EMBO Rep       Date:  2021-07-14       Impact factor: 8.807

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.